Andembry (Garadacimab-gxii)

Andembry (garadacimab-gxii) is an activated Factor XII (FXIIa) inhibitor (monoclonal antibody) used for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

Recommended Dosage:
The recommended dosage of Garadacimab-gxii is an initial loading dose of 400 mg (two injections of 200 mg) administered subcutaneously on the first day of treatment, followed by a maintenance dosage of 200 mg administered subcutaneously every month.
In case any dose of Garadacimab-gxii is missed, administer the dose as quickly as possible.

• Treatment with Garadacimab‑gxii 200 mg/1.2 mL may be responsible for interfering with activated partial thromboplastin time (aPTT) assays by prolonging clotting time because of Factor XII inhibition. This laboratory effect can result in misinterpretation of coagulation tests. Inform lab personnel in case the patient is receiving the treatment.
• There is no adequate information on garadacimab‑gxii use in pregnancy, though. However, in animal studies, there was no fetal harm at high doses. Since it crosses the placenta in the third trimester, treatment should only be given if the anticipated benefits outweigh the risks.
• Currently, it is not known if garadacimab‑gxii is excreted in breast milk. Transfer of monoclonal antibodies, like IgG, is possible, but the effects on breastfed infants are not known. Treatment should be based on the needs of the mother and the possible risks to the breastfeeding child.
• Garadacimab-gxii has been proven safe and effective only in individuals aged 12 and above for the prevention of hereditary angioedema. Its use in children below 12 years of age is not advised because of insufficient evidence.
• Clinical studies have examined only a small number of patients aged 65 and older. Studies indicated no significant difference in safety or efficacy in comparison with younger adults. Evaluate overall health when prescribing garadacimab-gxii 200 mg/1.2 mL injection to older patients.

What documents are required to import ANDEMBRY to India?

ANDEMBRY (garadacimab-gxii) injection can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is ANDEMBRY available in India?

ANDEMBRY (garadacimab-gxii injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Andembry in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

ANDEMBRY can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ANDEMBRY (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Andembry 200 mg/1.2 mL injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ANDEMBRY (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Andembry®?

Garadacimab-gxii is the Generic Name for the trade name drug Andembry®.

What is the Manufacturer's Name of Andembry®?

Andembry® is manufactured by CSL Behring LLC.

Is Andembry approved by the FDA?

Yes, Andembry is approved by the FDA. Date of first approval: June 16, 2025.

What is the dosage and form of Andembry® supplied?

Andembry is supplied for Injection: 200 mg/1.2 mL solution in a single-dose prefilled autoinjector and 200 mg/1.2 mL (167 mg/mL) solution in a single-dose prefilled syringe with a needle safety device for subcutaneous use.

What are the most common side effects of Andembry® 200 mg/1.2 mL injection?

The most commonly reported side effects of Andembry® are abdominal pain and nasopharyngitis.

How much does Andembry® 200 mg/1.2 mL injection cost in India?

Andembry® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Andembry prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Andembry 200 mg/1.2 mL cost in India, please call/WhatsApp +91-9310090915 or send an email to info@indianpharmanetwork.in.

Can Andembry® 200 mg/1.2 mL injections be available in SAARC countries?

Apart from Gulf countries, Andembry® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Andembry® injection in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Andembry® 200 mg/1.2 mL injection online in India?

Yes, one can buy Andembry 200 mg/1.2 mL online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Andembry® injection through legal channels.

What are the storage conditions of Andembry® 200 mg/1.2 mL injections?

Store the prefilled autoinjector and prefilled syringe with needle safety device refrigerated at 36°F to 46°F (2°C - 8°C). Neither freeze nor shake the vials. Keep the prefilled autoinjector and prefilled syringe with needle safety device in the original carton to protect from light.